Arcus Biosciences RCUS Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $201M-9.5% | $222M-6.7% | $238M-4.0% | $248M+29.2% | $192M+28.0% | ||
| $621M-18.2% | $759M+28.0% | $593M-10.6% | $663M-17.6% | $805M-2.8% | ||
| $3M— | —— | $3M0.0% | $3M0.0% | $3M— | ||
| $3M-72.7% | $11M0.0% | $11M-26.7% | $15M0.0% | $15M-25.0% | ||
| $4M-20.0% | $5M+66.7% | $3M-40.0% | $5M-16.7% | $6M+20.0% | ||
| $844M-16.2% | $1.01B+17.5% | $857M-9.4% | $946M-8.2% | $1.03B+1.5% | ||
| $38M-5.0% | $40M-4.8% | $42M-4.5% | $44M-4.3% | $46M-2.1% | ||
| $61M-3.2% | $63M-3.1% | $65M-5.8% | $69M-2.8% | $71M-2.7% | ||
| $54M+86.2% | $29M+190% | $10M-37.5% | $16M+100% | $8M-42.9% | ||
| $997M-12.5% | $1.14B+16.9% | $974M-9.4% | $1.08B-7.0% | $1.16B+0.5% | ||
| $39M-7.1% | $42M0.0% | $42M+44.8% | $29M+31.8% | $22M+22.2% | ||
| $19M-42.4% | $33M+17.9% | $28M+33.3% | $21M+23.5% | $17M-86.2% | ||
| $34M-2.9% | $35M-32.7% | $52M-26.8% | $71M-1.4% | $72M-15.3% | ||
| $13M0.0% | $13M0.0% | $13M+8.3% | $12M0.0% | $12M0.0% | ||
| $79M+1.3% | $78M-25.7% | $105M-19.8% | $131M-55.0% | $291M-8.8% | ||
| $1M0.0% | $1M— | —— | —— | —— | ||
| $10M-44.4% | $18M+12.5% | $16M0.0% | $16M-5.9% | $17M+13.3% | ||
| $209M-9.5% | $231M-1.7% | $235M+11.9% | $210M+9.4% | $192M-15.0% | ||
| $100M+1.0% | $99M+1.0% | $98M+1.0% | $97M+102% | $48M0.0% | ||
| $119M-11.9% | $135M-11.2% | $152M-4.4% | $159M-4.2% | $166M+5.7% | ||
| 400M0.0% | 400M0.0% | 400M0.0% | 400M0.0% | 400M-75.3% | ||
| -$1.61B-8.6% | -$1.49B-7.7% | -$1.38B-10.9% | -$1.24B0.0% | -$1.24B-9.9% | ||
| -$1M— | $0— | —— | —— | —— | ||
| $524M-17.0% | $631M+44.7% | $436M-20.6% | $549M+3.4% | $531M+9.5% | ||
| $997M-12.5% | $1.14B+16.9% | $974M-9.4% | $1.08B-7.0% | $1.16B+0.5% | ||
| $877M-13.2% | $1.01B+20.1% | $841M-9.3% | $927M-7.8% | $1.01B+1.3% | ||
| $204M-9.3% | $225M-6.6% | $241M-4.0% | $251M+28.7% | $195M+27.5% | ||
| $876M-13.3% | $1.01B+20.1% | $841M-9.3% | $927M-7.8% | $1.01B+1.3% | ||
| $621M-18.2% | $759M+28.0% | $593M-10.6% | $663M-17.6% | $805M-2.8% | ||
| $61M-3.2% | $63M-3.1% | $65M-5.8% | $69M-2.8% | $71M-2.7% | ||
| $877M-13.2% | $1.01B+20.1% | $841M-9.3% | $927M-7.8% | $1.01B+1.3% | ||
| $54M+86.2% | $29M+190% | $10M-37.5% | $16M+100% | $8M-42.9% | ||
| $61M-3.2% | $63M-3.1% | $65M-5.8% | $69M-2.8% | $71M-2.7% | ||
| $61M-3.2% | $63M-3.1% | $65M-5.8% | $69M-2.8% | $71M-2.7% | ||
| $19M-42.4% | $33M+17.9% | $28M+33.3% | $21M+23.5% | $17M-45.2% | ||
| $45M+4.7% | $43M-18.9% | $53M-11.7% | $60M-72.6% | $219M-6.4% | ||
| $19M-42.4% | $33M+17.9% | $28M+33.3% | $21M+23.5% | $17M-45.2% | ||
| $136M-11.7% | $154M+9.2% | $141M+28.2% | $110M+12.2% | $98M-20.3% | ||
| $45M+4.7% | $43M-18.9% | $53M-11.7% | $60M-72.6% | $219M-6.4% | ||
| —— | 12.9%-0.2% | 13.1%0.0% | 13.1%-0.3% | 13.4%— | ||
| $0-100% | $1M-50.0% | $2M-33.3% | $3M+50.0% | $2M0.0% | ||
| $45M+4.7% | $43M-18.9% | $53M-11.7% | $60M-72.6% | $219M-6.4% | ||
| $113M-42.9% | $198M+78.4% | $111M+1.8% | $109M+81.7% | $60M-62.3% | ||
| $100M0.0% | $100M0.0% | $100M0.0% | $100M+100% | $50M0.0% | ||
| $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | $0.000.0% | ||
| 125.5M+0.2% | 125.3M+17.0% | 107.1M+0.7% | 106.4M+0.5% | 105.9M+14.9% | ||
| $2.14B+1.0% | $2.12B+16.6% | $1.82B+1.2% | $1.79B+1.0% | $1.78B+9.8% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $1M— | $0— | $0— | $0— | $0— | ||
| 100+223% | 31+47.6% | 21-73.4% | 79+11.3% | 71+31.5% | ||
| $877M-13.2% | $1.01B+20.1% | $841M-9.3% | $927M-7.8% | $1.01B+1.3% | ||
| $93M+4.5% | $89M+6.0% | $84M+37.7% | $61M+17.3% | $52M-20.0% | ||
| $1M— | $0— | $0— | $0— | $0— | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $877M-13.2% | $1.01B+20.1% | $841M-9.3% | $927M-7.8% | $1.01B+1.3% | ||
| $876M-13.3% | $1.01B+20.1% | $841M-9.3% | $927M-7.8% | $1.01B+1.3% | ||
| $876M-13.3% | $1.01B+20.1% | $841M-9.3% | $927M-7.8% | $1.01B+1.3% | ||
| $204M-9.3% | $225M-6.6% | $241M-4.0% | $251M+28.7% | $195M+27.5% | ||
| $00.0% | $00.0% | $00.0% | $00.0% | $00.0% | ||
| $400M0.0% | $400M0.0% | $400M0.0% | $400M0.0% | $400M0.0% | ||
| $125.5M+0.2% | $125.3M+17.0% | $107.1M+0.7% | $106.4M+0.5% | $105.9M+14.9% | ||
| $125.5M+0.2% | $125.3M+17.0% | $107.1M+0.7% | $106.4M+0.5% | $105.9M+14.9% | ||
| $79M+1.3% | $78M-25.7% | $105M-19.8% | $131M-55.0% | $291M-8.8% | ||
| $100M0.0% | $100M0.0% | $100M0.0% | $100M+100% | $50M0.0% | ||
| $0-100% | $1M-50.0% | $2M-33.3% | $3M+50.0% | $2M0.0% | ||
| $100+223% | $31+47.6% | $21-73.4% | $79+11.3% | $71+31.5% | ||
| $4M-20.0% | $5M+66.7% | $3M-40.0% | $5M-16.7% | $6M+20.0% | ||
| $10M-44.4% | $18M+12.5% | $16M0.0% | $16M-5.9% | $17M+13.3% | ||
| $15M+50.0% | $10M-16.7% | $12M-20.0% | $15M+15.4% | $13M0.0% | ||
| —— | —— | $256M0.0% | $256M— | —— | ||
| —— | —— | —— | —— | $11.00— | ||
| $3M0.0% | $3M0.0% | $3M0.0% | $3M0.0% | $3M0.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Arcus Biosciences's total assets?
- Arcus Biosciences (RCUS) holds $997.0M in total assets, down 13.8% year over year.
- How much debt does Arcus Biosciences have?
- Arcus Biosciences carries $113.0M in total debt against $524.0M of shareholders' equity, a debt-to-equity ratio of 0.22.
- How much cash does Arcus Biosciences have?
- Arcus Biosciences holds $201.0M in cash and equivalents.
- Can Arcus Biosciences cover its short-term obligations?
- Its current ratio is 4.04 — current assets exceed current liabilities.
- Where does Arcus Biosciences's balance sheet data come from?
- Every line is extracted from Arcus Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
